Osaic Holdings’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1
Closed -$1K 7434
2022
Q2
$1K Sell
1
-2
-67% -$104 ﹤0.01% 7119
2022
Q1
$3K Sell
3
-6
-67% -$535 ﹤0.01% 6752
2021
Q4
$9K Buy
+9
New +$1.55K ﹤0.01% 6341

Other funds holding NVAX

Osaic Holdings's NVAX Position: Q1 2026 in Review

Osaic Holdings increased its Novavax (NVAX) stake by 4.7% in Q1 2026, buying an estimated $19.4K and bringing the position to 47,943 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Osaic Holdings first reported a position in NVAX in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.7M in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Osaic Holdings held 47,943 shares of Novavax worth $390K as of Q1 2026.
  • Osaic Holdings bought 2,142 Novavax shares in Q1 2026, an estimated $19.4K.
  • Novavax made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #3590 holding.
  • Osaic Holdings first reported a position in Novavax in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Novavax position peaked at $10.7M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.